News

October 20, 2020

Startup company founded by Washington University scientists acquired by Eli Lilly

Drugmaker purchases Disarm Therapeutics to develop treatments for neurodegenerative diseases.

Medical Campus & Community

July 29, 2019

Extending human life

Two new centers focus on chronic diseases of aging.

Outlook Magazine

January 16, 2019

Gene therapy blocks peripheral nerve damage in mice

Lays groundwork for developing treatments for peripheral neuropathy, other nerve diseases.

News Release